Soft tissue sarcoma - problems of diagnosis and treatment

被引:0
|
作者
Mesina, C. [1 ]
Vasile, I. [1 ]
Vilcea, I. D. [1 ]
Pasalega, M. [1 ]
Parvanescu, H. [2 ]
Calota, F. [1 ]
Georgescu, C. V. [3 ]
Ghilusi, M. [3 ]
Dumitrescu, T. [1 ]
Mirea, C. [1 ]
Mogoanta, S. [1 ]
Moraru, E. [1 ]
机构
[1] UMF Craiova, Spit Clin Judetean Urgenta Craiova, Clin Chirurg 2, Craiova, Dolj, Romania
[2] UMF Craiova, Spit Clin Judetean Urgenta, Clin Chirurg Plast, Craiova, Dolj, Romania
[3] Spit Clin Judetean Urgenta Craiova, Lab Anat Patol, Craiova, Romania
关键词
soft tissue sarcoma; rabdomyosarcoma; ISOLATED LIMB PERFUSION; GROWTH-FACTOR; MUSCULOSKELETAL TUMORS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; SYNOVIAL SARCOMA; PHASE-II; CANCER; BONE; CHEMOTHERAPY;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Soft tissue sarcomas are a rare group of cancers compromising 1% of all malignancies and there has been a slight increase in incidence. We present 3 cases of soft tissue sarcomas ( the tumors were located to the right axilary region, perianal and dorsale face of the left leg) hospitalized in 2nd Surgical Clinic of Emergency Hospital of Craiova and we discuss the difficulties of diagnosis and treatment. The classification and characterization of soft-tissue sarcomas have evolved as the information supplied by histologic analysis has been supplemented with that provided by immunohistochemical analysis. Surgical resection involving wide margins, with or without radiotherapy, offers the best chance of cure in the absence of metastatic disease. There is little evidence that local recurrence increases the likelihood of metastatic spread, although debate on this point continues. Except for rhabdomyosarcomas and Ewing's sarcomas, the use of adjuvant chemotherapy generally does little to influence the natural history of the disease. In conclusion surgical treatment is mainstay of treatment for soft-tissue sarcomas and is usefull the prompt diagnosis for decrease the risk of local recurrence and metastatic disease.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 50 条
  • [41] TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA
    ROSENBAUM, C
    SCHOENFELD, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 287 - 287
  • [42] Future directions in soft tissue sarcoma treatment
    Hall, Francis
    Villalobos, Victor
    Wilky, Breelyn
    CURRENT PROBLEMS IN CANCER, 2019, 43 (04) : 300 - 307
  • [43] Targeted Treatment of Soft-Tissue Sarcoma
    Riskjell, Anne Iren
    Makinen, Vivi-Nelli
    Sandfeld-Paulsen, Birgitte
    Aggerholm-Pedersen, Ninna
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [44] SOFT-TISSUE SARCOMA - TRENDS IN TREATMENT
    KARAKOUSIS, CP
    LOPEZ, RE
    RAO, U
    HOLYOKE, ED
    NEW YORK STATE JOURNAL OF MEDICINE, 1979, 79 (03) : 328 - 332
  • [45] Novel treatment strategies for soft tissue sarcoma
    Kasper, Bernd
    Gil, Thierry
    D'Hondt, Veronique
    Gebhart, Michael
    Awada, Ahmad
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (01) : 9 - 15
  • [46] Olaratumab for the treatment of advanced soft tissue sarcoma
    Okuno, Scott H.
    Maran, Avudaiappan
    Robinson, Steven I.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (10) : 883 - 887
  • [47] Pazopanib for the treatment of soft-tissue sarcoma
    Heudel, Pierre
    Cassier, Philippe
    Derbel, Olfa
    Dufresne, Armelle
    Meeus, Pierre
    Thiesse, Philippe
    Ranchere-Vince, Dominique
    Blay, Jean Yves
    Ray-Coquard, Isabelle
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2012, 4 : 65 - 70
  • [48] The value of trabectedin in the treatment of soft tissue sarcoma
    Nakamura, Tomoki
    Matsumine, Akihiko
    Sudo, Akihiro
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 73 - 79
  • [49] Multidisciplinary treatment for adult soft tissue sarcoma
    Lordick, F.
    CHIRURG, 2009, 80 (03): : 209 - 215
  • [50] Olaratumab for the treatment of soft-tissue sarcoma
    Pender, Alexandra
    Jones, Robin L.
    FUTURE ONCOLOGY, 2017, 13 (24) : 2151 - 2157